The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies
- PMID: 32920163
- DOI: 10.1016/j.aohep.2020.08.071
The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies
Abstract
Introduction and objectives: Non-alcoholic fatty liver disease (NAFLD) is a widespread chronic liver disease. It is considered a multifactorial disorder that can progress to liver fibrosis and cause a worldwide public health concern. Coffee consumption may have a protective impact on NAFLD and liver fibrosis. However, the evidence from the previous studies is inconsistent. This meta-analysis summarizes available literature.
Materials and methods: This study comprises two meta-analyses. The first meta-analysis summarizes the effect of coffee consumption on NAFLD in those who did or did not drink coffee. The second analysis compares the risk of liver fibrosis development between NAFLD patients who did or did not drink coffee. Pooled risk ratios (RR) and confidence intervals (CI) of observational studies were estimated.
Results: Of the total collected 321 articles, 11 met our eligibility criteria to be included in the analysis. The risk of NAFLD among those who drank coffee compared to those who did not was significantly lower with a pooled RR value of 0.77 (95% CI 0.60-0.98). Moreover, we also found a significantly reduced risk of liver fibrosis in those who drink coffee than those who did not drink in the NAFLD patients with the relative risk (RR) of 0.68 (95% CI 0.68-0.79).
Conclusions: Regular coffee consumption is significantly associated with a reduced risk of NAFLD. It is also significantly associated with decreased risk of liver fibrosis development in already diagnosed NAFLD patients. Although coffee consumption may be considered an essential preventive measure for NAFLD, this subject needs further epidemiological studies.
Keywords: Caffeine; Coffee; Confidence interval; Meta-analysis; NAFLD (non-alcoholic fatty liver disease); NASH (Non-alcoholic steatohepatitis); Relative risk.
Copyright © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596. eCollection 2021. Front Pharmacol. 2021. PMID: 34966282 Free PMC article. Review.
-
Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.Nutrients. 2021 Aug 30;13(9):3042. doi: 10.3390/nu13093042. Nutrients. 2021. PMID: 34578919 Free PMC article.
-
A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease.Clin Nutr. 2019 Dec;38(6):2552-2557. doi: 10.1016/j.clnu.2018.11.030. Epub 2018 Dec 4. Clin Nutr. 2019. PMID: 30573353
-
Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.Eur J Gastroenterol Hepatol. 2017 Feb;29(2):e8-e12. doi: 10.1097/MEG.0000000000000776. Eur J Gastroenterol Hepatol. 2017. PMID: 27824642 Review.
-
Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.Clin Nutr. 2016 Dec;35(6):1269-1281. doi: 10.1016/j.clnu.2016.03.012. Epub 2016 Mar 30. Clin Nutr. 2016. PMID: 27060021 Review.
Cited by
-
Practical Lifestyle Management of Nonalcoholic Fatty Liver Disease for Busy Clinicians.Diabetes Spectr. 2024 Winter;37(1):39-47. doi: 10.2337/dsi23-0009. Epub 2024 Feb 15. Diabetes Spectr. 2024. PMID: 38385102 Free PMC article.
-
Different Associations of Coffee Consumption with the Risk of Incident Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Liver Fibrosis.Nutrients. 2023 Dec 31;16(1):140. doi: 10.3390/nu16010140. Nutrients. 2023. PMID: 38201969 Free PMC article.
-
Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease.Medicina (Kaunas). 2023 Oct 8;59(10):1789. doi: 10.3390/medicina59101789. Medicina (Kaunas). 2023. PMID: 37893507 Free PMC article. Review.
-
Coffee, adenosine, and the liver.Purinergic Signal. 2024 Feb;20(1):21-28. doi: 10.1007/s11302-023-09968-5. Epub 2023 Sep 27. Purinergic Signal. 2024. PMID: 37755557 Free PMC article. Review.
-
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2023 Sep 18;10:1547-1571. doi: 10.2147/JHC.S404424. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37744303 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous